Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy.

Abstract excerpt

INTRODUCTION: There are approximately 70 million people with epilepsy and about 30% of patients are not satisfactorily treated. A link between gene mutations and epilepsy is well documented. A number of pathological variants of KCNT1 gene (encoding the weakly voltage-dependent sodium-activated potassium channel - KNa 1.1) mutations has been found. For instance, epilepsy of infancy with migrating focal seizures,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anticonvulsants
• Share to Epilepsy
• Share to Mutation